Together, these data show that while CD24 is expressed in both models during tumor development, CD24 deficiency had no significant effect on the initiation of tumors and subsequently reduced tumor burden in a statistically significant manner only in Apc1572T/+ mice, albeit marginally. This evidence concerns the gene CD24 and neoplasm.